19:30 IST
NSE
Annual General Meeting
Curis Lifesciences Annual General Meeting
Curis Lifesciences filed its 10th AGM notice and FY 2025-26 Annual Report. The meeting is scheduled for September 29, 2026.
Curis Lifesciences Ltd
- Share price
- ₹223.65
- Market cap
- ₹180.8 Cr
- Revenue (annual)
- ₹60.63 Cr
- Net profit (annual)
- ₹6.92 Cr
- P/E (TTM)
- 26.1×Sector 50.4×
- Promoter holding
- 68.03%
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
19:00 IST
NSE
Board Meeting Outcome
Curis Lifesciences Board Meeting Outcome
Curis Lifesciences Limited approved the Director's Report, related party transactions, and scheduled its 10th Annual General Meeting for September 29, 2026. Board outcomes were finalized.
19:12 IST
NSE
Management Change
Curis Lifesciences Management Change
Curis Lifesciences Limited announced the resignation of Mr. Nikhil Purohit as Company Secretary and Compliance Officer, effective September 3, 2026.
21:09 IST
NSE
Financial Results
Curis Lifesciences H2 FY26 Results: Net Profit ₹2.7 Cr, Down 32.5% YoY
Curis Lifesciences Ltd reported revenue from operations of ₹32.7 Cr (-4.9% YoY) and net profit of ₹2.7 Cr (-32.5% YoY) for H2 FY26.
- Key figure
- Net profit ₹2.7 Cr · -32.5% YoY